- Home
- ZOOZ vs LPCN Comparison
ZOOZ vs LPCN Comparison
Compare ZOOZ & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZOOZ
- LPCN
- Stock Information
- Founded
- ZOOZ 2013
- LPCN 1997
- Country
- ZOOZ Israel
- LPCN United States
- Employees
- ZOOZ N/A
- LPCN N/A
- Industry
- ZOOZ
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- ZOOZ
- LPCN Health Care
- Exchange
- ZOOZ NYSE
- LPCN Nasdaq
- Market Cap
- ZOOZ 34.7M
- LPCN 36.8M
- IPO Year
- ZOOZ N/A
- LPCN N/A
- Fundamental
- Price
- ZOOZ $2.87
- LPCN $4.98
- Analyst Decision
- ZOOZ Strong Buy
- LPCN Strong Buy
- Analyst Count
- ZOOZ 1
- LPCN 1
- Target Price
- ZOOZ $5.00
- LPCN $10.00
- AVG Volume (30 Days)
- ZOOZ 11.1K
- LPCN 30.1K
- Earning Date
- ZOOZ 02-16-2025
- LPCN 11-07-2024
- Dividend Yield
- ZOOZ N/A
- LPCN N/A
- EPS Growth
- ZOOZ N/A
- LPCN N/A
- EPS
- ZOOZ N/A
- LPCN N/A
- Revenue
- ZOOZ $506,656.00
- LPCN $7,922,926.00
- Revenue This Year
- ZOOZ N/A
- LPCN N/A
- Revenue Next Year
- ZOOZ $37.50
- LPCN N/A
- P/E Ratio
- ZOOZ N/A
- LPCN N/A
- Revenue Growth
- ZOOZ N/A
- LPCN N/A
- 52 Week Low
- ZOOZ $1.66
- LPCN $2.44
- 52 Week High
- ZOOZ $4.60
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- ZOOZ N/A
- LPCN 50.88
- Support Level
- ZOOZ N/A
- LPCN $4.70
- Resistance Level
- ZOOZ N/A
- LPCN $5.28
- Average True Range (ATR)
- ZOOZ 0.00
- LPCN 0.32
- MACD
- ZOOZ 0.00
- LPCN 0.04
- Stochastic Oscillator
- ZOOZ 0.00
- LPCN 69.53
About ZOOZ ZOOZ POWER LTD
Zooz Power Ltd is a provider of Flywheel-based Power Boosting solutions enabling widespread deployment of ultra-fast charging infrastructure for electric vehicles (EV) while overcoming existing grid limitations. ZOOZ pioneers its flywheel-based power boosting technology, enabling efficient utilization and power management of a power-limited grid at an EV charging site. Its Flywheel technology allows high-performance, reliable, and cost-effective ultra-fast charging infrastructure. ZOOZ Power's sustainable, power-boosting solutions are built with longevity and the environment in mind, helping its customers and partners accelerate the deployment of fast-charging infrastructure, thus facilitating improved utilization rates, efficiency, and greater flexibility.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.